MS-DRG 840 — Lymphoma and Non-acute Leukemia with MCC
MDC 17 · Myeloproliferative Diseases & Neoplasms · Medical DRG · FY2026
| FY2026 relative weight | 3.2349 |
|---|---|
| Geometric mean LOS | 6.8 days |
| Arithmetic mean LOS | 9.7 days |
| Severity tier | with MCC |
| Post-acute transfer policy | Yes — per-diem reduction applies to qualifying transfers |
| Special payment provision | No |
Severity family — documentation moves the weight 3.20×
The same base condition splits by coded severity (CC/MCC). Weight deltas here are exactly what one documented comorbidity is worth:
| DRG | Title | FY2026 weight | GMLOS |
|---|---|---|---|
| 840 | Lymphoma and Non-acute Leukemia with MCC | 3.2349 | 6.8 |
| 841 | Lymphoma and Non-acute Leukemia with CC | 1.6314 | 4.0 |
| 842 | Lymphoma and Non-acute Leukemia without CC/MCC | 1.0104 | 2.6 |
Figures come from the official FY2026 IPPS tables and are payment inputs, not adjudicated amounts. DRG Calculator prices full claims — hospital-specific operating, capital, IME, DSH, uncompensated care and outlier math — and verifies results against the official pricer.